Home › Funds › Jackson National › JNL/Invesco Small Cap Growth Fund
Fund family: Jackson National · Filed by JNL SERIES TRUST (CIK 933691) · SEC series S000001743
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 774 with, 5 against, 5 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Jackson National’s manager page (239,981 ballot items across 107 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Jackson National | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.0% | 754 | 92.4% | 203,335 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 2.8% | 2,611 |
Each ballot item this fund voted is set against the votes of the other Jackson National funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Jackson National funds on 55 items (8.7% of the 634 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Jackson National funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS, INC. | 2026-06-04 | To make an advisory vote on executive compensation. | Against | FOR — 10 of 10 Jackson National funds | Against | Approved, 96.4% support |
| SPX TECHNOLOGIES, INC. | 2026-05-12 | Approval of Named Executive Officers' Compensation, on a Non-binding Advisory Basis. | Against | FOR — 9 of 9 Jackson National funds | Against | Approved, 94.1% support |
| TALEN ENERGY CORPORATION | 2026-05-05 | To approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 8 of 8 Jackson National funds | Against | Approved, 96.7% support |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | 2025-10-21 | Election of Directors: Joe A. Raver | Withhold | FOR — 8 of 8 Jackson National funds | Against | Passed (calculated), 89.0% support |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | DIRECTOR: L.T. Williams, MD, PhD | For | ABSTAIN — 7 of 7 Jackson National funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 7 of 7 Jackson National funds | Against | Approved, 94.4% support |
| CYTOKINETICS, INCORPORATED | 2026-05-27 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. | Against | FOR — 7 of 7 Jackson National funds | Against | Approved, 97.2% support |
| FABRINET | 2025-12-11 | DIRECTOR: Dr. Homa Bahrami | Abstain | FOR — 6 of 6 Jackson National funds | Against | — |
| ESCO TECHNOLOGIES INC. | 2026-01-30 | Election of Directors: Robert J. Phillippy | Withhold | FOR — 6 of 6 Jackson National funds | Against | Elected, 87.4% support |
| CASELLA WASTE SYSTEMS, INC. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle Green | For | WITHHOLD — 6 of 6 Jackson National funds | For | Elected, 66.5% support |
| CAVCO INDUSTRIES, INC. | 2025-07-29 | Election of Directors David A. Greenblatt | Against | FOR — 6 of 6 Jackson National funds | Against | — |
| BOOT BARN HOLDINGS, INC. | 2025-08-27 | Election of Directors: Lisa G. Laube | Withhold | FOR — 6 of 6 Jackson National funds | Against | Elected, 78.3% support |
| TRANSMEDICS GROUP, INC. | 2026-05-20 | To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2 | For | AGAINST — 6 of 6 Jackson National funds | For | — |
| TRANSMEDICS GROUP, INC. | 2026-05-20 | To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. | Against | FOR — 6 of 6 Jackson National funds | Against | Approved, 95.2% support |
| BLOOM ENERGY CORPORATION | 2026-05-21 | DIRECTOR: Barbara Burger | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| BLOOM ENERGY CORPORATION | 2026-05-21 | DIRECTOR: Eddy Zervigon | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| BRIDGEBIO PHARMA, INC. | 2026-06-22 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Against | FOR — 5 of 5 Jackson National funds | Against | Approved, 95.7% support |
| GLAUKOS CORPORATION | 2026-05-28 | DIRECTOR: Denice M. Torres | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| RED ROCK RESORTS, INC. | 2026-06-04 | DIRECTOR: James E. Nave, D.V.M. | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| RED ROCK RESORTS, INC. | 2026-06-04 | DIRECTOR: Robert A. Cashell, Jr. | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| RED ROCK RESORTS, INC. | 2026-06-04 | DIRECTOR: Robert E. Lewis | For | ABSTAIN — 5 of 5 Jackson National funds | For | — |
| CARPENTER TECHNOLOGY CORPORATION | 2025-10-07 | DIRECTOR: Stephen M. Ward, Jr. | Abstain | FOR — 8 of 9 Jackson National funds | Against | — |
| CAVA GROUP INC | 2026-06-22 | Election of Class III Directors James D. White | For | WITHHOLD — 7 of 8 Jackson National funds | For | — |
| STEPSTONE GROUP INC | 2025-09-09 | To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification. Scott W. Hart | Withhold | FOR — 4 of 4 Jackson National funds | Against | — |
| CARGURUS, INC. | 2026-06-03 | DIRECTOR: Langley Steinert | For | ABSTAIN — 4 of 4 Jackson National funds | For | — |
| Company | Meeting | Item | This fund | Most Jackson National funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| CARGURUS, INC. | 2026-06-03 | DIRECTOR: Manik Gupta | For | ABSTAIN — 4 of 4 Jackson National funds | For | — |
| CARGURUS, INC. | 2026-06-03 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for 2025. | For | AGAINST — 4 of 4 Jackson National funds | For | — |
| BIOLIFE SOLUTIONS, INC. | 2025-08-20 | DIRECTOR: Joydeep Goswami | For | ABSTAIN — 4 of 4 Jackson National funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | DIRECTOR: Dinesh V. Patel, Ph.D. | For | ABSTAIN — 6 of 7 Jackson National funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | For | AGAINST — 6 of 7 Jackson National funds | For | Approved, 84.4% support |
| API GROUP CORPORATION | 2026-05-15 | To elect nine directors for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Cyrus D. Walker | For | AGAINST — 7 of 9 Jackson National funds | For | Passed (calculated), 81.1% support |
| WYNDHAM HOTELS & RESORTS, INC. | 2026-05-14 | Shareholder To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. | Against | FOR — 7 of 9 Jackson National funds | For | Passed (calculated), 62.9% support |
| KARMAN HOLDINGS INC. | 2026-04-29 | DIRECTOR: Stephen Twitty | For | ABSTAIN — 3 of 3 Jackson National funds | For | — |
| RBC BEARINGS INCORPORATED | 2025-09-04 | Election of Directors Edward D. Stewart | Against | FOR — 6 of 8 Jackson National funds | Against | — |
| ZURN ELKAY WATER SOLUTIONS CORPORATION | 2026-04-30 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. | Against | FOR — 6 of 8 Jackson National funds | Against | Passed (calculated), 87.6% support |
| PERMIAN RESOURCES CORPORATION | 2026-05-19 | To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan. | For | AGAINST — 8 of 12 Jackson National funds | For | Passed (calculated), 71.8% support |
| STEPSTONE GROUP INC | 2025-09-09 | To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification. Monte M. Brem | Withhold | FOR — 4 of 5 Jackson National funds | Against | — |
| BRIGHTSPRING HEALTH SERVICES, INC. | 2026-05-21 | Election of Class II directors Steve Miller | Withhold | FOR — 5 of 7 Jackson National funds | Against | — |
| MUELLER INDUSTRIES, INC. | 2026-05-07 | DIRECTOR: Elizabeth Donovan | For | ABSTAIN — 6 of 9 Jackson National funds | For | — |
| CLEAN HARBORS, INC. | 2026-05-20 | To approve on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Company's definitive proxy statement. | For | AGAINST — 5 of 8 Jackson National funds | For | Passed (calculated), 94.6% support |
| RBC BEARINGS INCORPORATED | 2025-09-04 | Election of Directors Barry C. Boyan | For | AGAINST — 5 of 8 Jackson National funds | For | — |
| RBC BEARINGS INCORPORATED | 2025-09-04 | Election of Directors Daniel A. Bergeron | For | AGAINST — 5 of 8 Jackson National funds | For | — |
| EVERCORE INC. | 2026-06-10 | Approval of the Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan. | Against | FOR — 5 of 8 Jackson National funds | Against | Approved, 68.0% support |
| EVERCORE INC. | 2026-06-10 | Election of Directors. Roger C. Altman | For | AGAINST — 5 of 8 Jackson National funds | For | — |
| EVERCORE INC. | 2026-06-10 | To approve, on an advisory basis, the executive compensation of our Named Executive Officers. | For | AGAINST — 5 of 8 Jackson National funds | For | Approved, 94.2% support |
| HAMILTON LANE INCORPORATED | 2025-09-04 | Advisory, non-binding vote to approve named executive officer compensation. | Against | FOR — 5 of 8 Jackson National funds | Against | Approved, 76.2% support |
| OSI SYSTEMS, INC. | 2025-12-11 | Election of Directors William F. Ballhaus | Against | FOR — 5 of 8 Jackson National funds | Against | — |
| GUARDANT HEALTH, INC. | 2026-06-17 | Election of Class II Directors Ian Clark | For | WITHHOLD — 3 of 4 Jackson National funds | For | — |
| GUARDANT HEALTH, INC. | 2026-06-17 | Election of Class II Directors Manuel Hidalgo Medina | For | WITHHOLD — 3 of 4 Jackson National funds | For | — |
| BRIDGEBIO PHARMA, INC. | 2026-06-22 | DIRECTOR: Hannah A. Valantine, MD | For | ABSTAIN — 3 of 4 Jackson National funds | For | — |
| PIPER SANDLER COMPANIES | 2026-05-20 | Election of Directors Jonathan J. Doyle | For | AGAINST — 4 of 6 Jackson National funds | For | — |
| COGNEX CORPORATION | 2026-04-29 | To approve, on an advisory basis, the compensation of Cognex's named executive officers, as described in the proxy statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion ("say-on-pay"). | Against | FOR — 4 of 7 Jackson National funds | Against | Approved, 78.7% support |
| TRAVEL + LEISURE CO. | 2026-05-20 | DIRECTOR: George Herrera | For | ABSTAIN — 4 of 7 Jackson National funds | For | — |
| GUARDANT HEALTH, INC. | 2026-06-17 | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. | Against | FOR — 3 of 5 Jackson National funds | Against | Not approved, 90.8% support |
| ROCKET LAB CORPORATION | 2025-08-27 | DIRECTOR: Jon Olson | For | ABSTAIN — 2 of 3 Jackson National funds | For | — |
Download all 55 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 88.5% of this fund’s 784 such votes could be given a sector; the other 90 (11.5%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Industrials | 190 | 3 | 1.6% |
| Technology | 111 | 1 | 0.9% |
| Consumer Discretionary | 109 | 1 | 0.9% |
| Health Care | 105 | 0 | 0.0% |
| Finance | 77 | 0 | 0.0% |
| Energy | 31 | 0 | 0.0% |
| Utilities | 26 | 0 | 0.0% |
| Consumer Staples | 12 | 0 | 0.0% |
| Real Estate | 12 | 0 | 0.0% |
| Miscellaneous | 11 | 0 | 0.0% |
| Telecommunications | 6 | 0 | 0.0% |
| Basic Materials | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 526 | 0 |
| Audit-related | 101 | 0 |
| Say-on-Pay | 97 | 0 |
| Compensation | 21 | 0 |
| Capital Structure | 19 | 1 |
| Corporate Governance | 19 | 3 |
| Other | 6 | 0 |
| Shareholder Rights and Defenses | 3 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES, INC. | May 21, 2026 | $53M | 5 | 0 |
| MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC | March 5, 2026 | $47M | 10 | 0 |
| SANMINA CORPORATION | March 9, 2026 | $43M | 12 | 1 |
| LATTICE SEMICONDUCTOR CORPORATION | May 1, 2026 | $35M | 10 | 0 |
| GLAUKOS CORPORATION | May 28, 2026 | $35M | 4 | 0 |
| BRIDGEBIO PHARMA, INC. | June 22, 2026 | $31M | 7 | 0 |
| GUARDANT HEALTH, INC. | June 17, 2026 | $30M | 5 | 0 |
| MKS, INC. | May 11, 2026 | $29M | 8 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 9, 2026 | SANMINA CORPORATION | To consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| May 11, 2026 | MKS, INC. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 14, 2026 | FLOWSERVE CORPORATION | Shareholder Proposal requesting an annual advisory shareholder vote regarding Flowserve stock repurchases. Shareholder proposal | Against | For |
| August 4, 2025 | EAGLE MATERIALS INC. | Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposal | For | Against |
| May 14, 2026 | WYNDHAM HOTELS & RESORTS, INC. | To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposal | Against | For |
792 ballot items at 96 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, JNL/Invesco Small Cap Growth Fund voted at 96 shareholder meetings of 96 companies, on 792 ballot items in all. Where management made a recommendation, the fund followed it on 98.7% of the items and voted against it 5 times. Its most frequent area of disagreement was corporate governance (3 of its votes against management). It voted on 5 shareholder proposals. It voted FOR the board's own proposals more often than Jackson National's funds as a whole (95.0% against 92.4%). It voted differently from most Jackson National funds on 55 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Jackson National’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.